Doseloop Beta

Colesevelam

medication Under review

A bile acid sequestrant medication used to lower LDL cholesterol and improve glycemic control in type 2 diabetes.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from randomized controlled trials and real-world studies primarily demonstrates colesevelam's efficacy in reducing LDL cholesterol and improving glycemic control when added to existing therapies. Research consensus supports its safety and tolerability profile, with consistent reductions in LDL-C by 13-21% and HbA1c by 0.3-0.5% in relevant populations, though direct studies in healthy humans without conditions are limited.

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

RCT

Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea

ClinicalTrials.gov • 2019 • n=170
RCT

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients with Primary Hyperlipidemia or Type 2 Diabetes Mellitus

Drugs Aging • 2014 • n=535
Cohort study

Real-world utilization patterns and outcomes of colesevelam HCl in patients with type 2 diabetes

Journal of Diabetes & Metabolic Disorders • 2013 • n=1747

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 0
Side effects noted 1